These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 13984037)

  • 1. The clinical significance of extracellular material (ECM) in L.E.-cell preparations. I. Analysis at the time of the first abnormal test.
    STEVENS MB; ABBEY H; SHULMAN LE
    N Engl J Med; 1963 May; 268():976-82. PubMed ID: 13984037
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship of systemic lupus erythematosus (SLE) to rheumatoid arthritis (RA), discoid lupus erythematosus (DLE) and Sjögren's syndrome. A clinical study.
    Bencze G
    Acta Rheumatol Scand; 1970; 16(3):191-6. PubMed ID: 5488864
    [No Abstract]   [Full Text] [Related]  

  • 3. RELATIONSHIP OF SYSTEMIC LUPUS ERYTHEMATOSUS TO RHEUMATOID ARTHRITIS, DISCOID LUPUS ERYTHEMATOSUS, AND SJOEGREN'S SYNDROME: A CLINICAL STUDY.
    BENCZE G; LAKATOS L
    Ann Rheum Dis; 1963 Jul; 22(4):273-5. PubMed ID: 14043591
    [No Abstract]   [Full Text] [Related]  

  • 4. A family survey of lupus erythematosus. 1. Heritability.
    Lawrence JS; Martins CL; Drake GL
    J Rheumatol; 1987 Oct; 14(5):913-21. PubMed ID: 3430520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squamous cell carcinoma arising in a recent plaque of discoid lupus erythematous, in a sun-protected area.
    Parikh N; Choi J; Li M; Sharma R; Fernandez-Peñas P
    Lupus; 2010 Feb; 19(2):210-2. PubMed ID: 19900979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)].
    Horvat Z
    Acta Med Iugosl; 1970; 24(3):229-40. PubMed ID: 4928076
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of tubuloreticular structures in circulating lymphocytes of patients with erythematodes].
    Horváth A; Schaff Z; Kramer M; Szepesházi K; Ablonczy E; Bognár A; Király K; Lapis K
    Orv Hetil; 1977 Feb; 118(9):500-3. PubMed ID: 840483
    [No Abstract]   [Full Text] [Related]  

  • 8. Antinuclear factors, rheumatoid factors and Bordet-Wassermann reaction in chronic and systemic lupus erythematosus.
    Strejcek J; Malina L; Bielický T
    Acta Derm Venereol; 1968; 48(3):198-202. PubMed ID: 4176741
    [No Abstract]   [Full Text] [Related]  

  • 9. [Erythematosus systemic (diagnostic and therapeutic difficulties)].
    Bratkowska-Seniów B
    Pol Tyg Lek; 1969 Jun; 24(25):949-51. PubMed ID: 5805053
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostic, prognostic and therapeutic aspects of systemic lupus erythematosus and rheumatoid arthritis.
    Weyand C
    Klin Wochenschr; 1990; 68 Suppl 21():55-63. PubMed ID: 2198390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythematosus with generalized chronic cutaneous (discoid) lupus erythematosus.
    Dadlani C; Pulitzer M; Prystowsky SD
    Dermatol Online J; 2008 May; 14(5):5. PubMed ID: 18627741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discoid lupus erythematosus and tuberculosis simulating systemic lupus erythematosus.
    Barfield C; Masi AT
    Arch Intern Med; 1980 May; 140(5):715-7. PubMed ID: 7396602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal laboratory test results and their relationship to prognosis in discoid lupus erythematosus. A long-term follow-up study of 92 patients.
    Millard LG; Rowell NR
    Arch Dermatol; 1979 Sep; 115(9):1055-8. PubMed ID: 314780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photobiology of lupus erythematosus.
    Baer RL; Harber LC
    Arch Dermatol; 1965 Aug; 92(2):124-8. PubMed ID: 11850910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
    Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
    Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lupus erythematosus. 5. Current status and trends in therapy of lupus erythematosus: a) S.L.E.: therapy with antimalarials, steroid therapy and monitoring, acupuncture; b) D.L.E.; c) Therapy of oral lesions and xerostomia; d) Dental treatment during L.E].
    Frojo M; Palomba F; Rullo R
    Arch Stomatol (Napoli); 1989 Nov; 30(5):1113-25. PubMed ID: 2641870
    [No Abstract]   [Full Text] [Related]  

  • 17. Rheumatoid and lupus-erythematosus-like syndromes; complications of hydralazine (apresoline) therapy for hypertension.
    BRUNSTING LA; ERICKSON JG; HINES EA; PEASE GL
    AMA Arch Derm; 1956 Dec; 74(6):640-7. PubMed ID: 13371922
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence of alopecia areata in lupus erythematosus.
    Werth VP; White WL; Sanchez MR; Franks AG
    Arch Dermatol; 1992 Mar; 128(3):368-71. PubMed ID: 1550369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Path-finder: lupus erythematosus and the L.E. cell.
    Blum LL
    J Indiana State Med Assoc; 1971 Jan; 64(1):34-5. PubMed ID: 4099845
    [No Abstract]   [Full Text] [Related]  

  • 20. [Disseminated lupus erythematous of polyarthritic type].
    COSTE F; TURIAF J; BLANCHON P
    Bull Mem Soc Med Hop Paris; 1953; 69(5-6):143-50. PubMed ID: 13042647
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.